Live from the NIH registry
Studies recruiting near San Diego right now
Top 25 of 1,354 recruiting studies, sorted by proximity — each links to its official registry page
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
University of California San Diego Moores Cancer Center (Adults only) — La Jolla, California (8.9 mi)
· Sponsor: Pierre Fabre Medicament
OssiMend BA in Posterolateral Instrumented Lumbar Fusion
Spinal Disease, Degenerative Disc Disease
N/A
Observational 120 participants sought
San Diego Neurosurgery — Encinitas, California (17.3 mi)
· Sponsor: Collagen Matrix
Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections
Gram-negative Bacterial Infections
Phase 2
Interventional 48 participants sought
Rady Children's Hospital — San Diego, California (8.4 mi)
· Sponsor: Pfizer
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Rady Children's Hospital - San Diego — San Diego, California (8.4 mi)
· Sponsor: National Cancer Institute (NCI)
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1
Interventional 30 participants sought
University of California San Diego — San Diego, California (8.4 mi)
· Sponsor: Acepodia Biotech, Inc.
BladdEr Full OR Empty for Pelvic Radiation Therapy
Pelvic Neoplasm
Phase 3
Interventional 300 participants sought
University of California, San Diego — San Diego, California (8.4 mi)
· Sponsor: University of California, San Diego
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — San Diego, California (8.4 mi)
· Sponsor: Sameek Roychowdhury
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
University of California San Diego Moores Cancer Center — San Diego, California (8.4 mi)
· Sponsor: Relay Therapeutics, Inc.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Rady Children's Hospital - San Diego — San Diego, California (8.4 mi)
· Sponsor: Medtronic MiniMed, Inc.
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Depressed Mood
N/A
Observational 5,000 participants sought
Salma Health — La Jolla, California (8.9 mi)
· Sponsor: Salma Health, Inc.
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Overweight , Obesity, Adults
Phase 2
Interventional 220 participants sought
Profound Research — Oceanside, California (29.3 mi)
· Sponsor: Alveus Therapeutics, Inc.
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder
Phase 2
Interventional 15 participants sought
UCSD Altman Clinical and Translational Research Institute Building — La Jolla, California (8.9 mi)
· Sponsor: Amgen
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Phase 1
Interventional 9 participants sought
University of California, San Diego — La Jolla, California (8.9 mi)
· Sponsor: Rocket Pharmaceuticals Inc.
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Large B-cell Lymphoma
Phase 2
Interventional 250 participants sought
University of California, San Diego — San Diego, California (8.4 mi)
· Sponsor: Allogene Therapeutics
Targeting Minority Stressors to Improve Eating Disorder Symptoms in Sexual Minority Individuals With Eating Disorders
Eating Disorders, Sexual Minorities
Phase 1
Interventional 30 participants sought
San Diego State University — San Diego, California (8.4 mi)
· Sponsor: Auburn University
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Scripps Health — La Jolla, California (8.9 mi)
· Sponsor: Hoffmann-La Roche
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — La Jolla, California (8.9 mi)
· Sponsor: AstraZeneca
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Phase 3
Interventional 942 participants sought
Acclaim Clinical Research- Site Number : 8400068 — San Diego, California (8.4 mi)
· Sponsor: Sanofi
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Clinical Applications Laboratories, Inc — San Diego, California (8.4 mi)
· Sponsor: Janssen Research & Development, LLC
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Prostate Cancer
Phase 4
Interventional 142 participants sought
University of California San Diego Health — San Diego, California (8.4 mi)
· Sponsor: Blue Earth Diagnostics
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente-San Diego Mission — San Diego, California (8.4 mi)
· Sponsor: SWOG Cancer Research Network
UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions
Brain Metastases, Adult, Neurocognitive Function
Phase 2
Interventional 90 participants sought
Moores Cancer Center — San Diego, California (8.4 mi)
· Sponsor: Jona Hattangadi-Gluth
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Parkinson Disease
N/A
Observational 4,500 participants sought
University of California San Diego — La Jolla, California (8.9 mi)
· Sponsor: Michael J. Fox Foundation for Parkinson's Research
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
Melanoma Stage III, Melanoma Stage IV
Phase 2
Interventional 25 participants sought
UC San Diego Moores Cancer Center — La Jolla, California (8.9 mi)
· Sponsor: University of California, San Francisco
Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health
Breastfeeding, COVID-19 Infection
N/A
Observational 5,000 participants sought
University of California, San Diego — San Diego, California (8.4 mi)
· Sponsor: University of California, San Diego